Results of EdU assay showed that compared with the RECK NC group, overexpression of RECK inhibited the viability of glioma cells, while transfection of both overexpressed RECK and overexpressed miR-30b-3p at the same time restored viability of glioma cells (Figure 5A). Here, RECK is linked to central nervous system cancer.